BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• BioMidwest

  Sermonix Pharmaceuticals Announces Five Abstracts Accepted for Presentation at 2023 San Antonio Breast Cancer Symposium

  Sermonix Pharmaceuticals Inc. today announced that it had five abstracts accepted as poster presentations at the 2023 San Antonio Breast Cancer Symposium (SABCS), which will be held Dec. 5-9 at the Henry B. Gonzalez Convention Center in San Antonio.

  November 28, 2023

   · 

  5 min read
• Genetown

  Candel Therapeutics Announces Restructuring to Prioritize Resources on Key Value Drivers for Expanded Development of CAN-3110, the enLIGHTEN™ Discovery Platform, and Key Clinical Readouts for CAN-2409

  Candel Therapeutics, Inc. today announced a strategic restructuring to focus on continuation and expansion of development of CAN-3110 as well as the enLIGHTEN™ Discovery Platform, while reducing the Company’s workforce and expenses associated with enabling commercial readiness of CAN-2409.

  November 28, 2023

   · 

  10 min read
• Biotech Bay

  180 Life Sciences Announces Review of Strategic Alternatives

  180 Life Sciences Corp., announced that its Board of Directors has initiated a process to evaluate potential strategic alternatives with the intent to unlock and maximize shareholder value.

  November 28, 2023

   · 

  8 min read
• Business

  Nyxoah Strengthens its Executive Leadership Team - November 28, 2023

  Nyxoah SA, a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea, announced the appointment of Francis Kim as Chief Regulatory and Quality Officer.

  November 28, 2023

   · 

  2 min read
• Business

  Ainos Announces Successful Manufacturing of VELDONA GMP Clinical Batch by Swiss Pharmaceutical

  Ainos, Inc. today announced that its contract manufacturer, Swiss Pharmaceutical Co., Ltd. (Taiwan) (“Swiss Pharma”), has completed manufacturing of a Good Manufacturing Practice (“GMP”) Clinical Batch of the Company’s VELDONA® investigational new drugs.

  November 28, 2023

   · 

  8 min read
• Lone Star Bio

  Monogram Orthopaedics Delivers First Surgical Robot

  Monogram Orthopaedics Inc. has delivered its first surgical robot to one of the world’s largest global robotics distributors.

  November 28, 2023

   · 

  3 min read